PRINTER'S NO. 1613
THE GENERAL ASSEMBLY OF PENNSYLVANIA
HOUSE RESOLUTION
No.
284
Session of
2019
INTRODUCED BY SCHROEDER, BERNSTINE, BURNS, CALTAGIRONE,
DiGIROLAMO, FREEMAN, HILL-EVANS, KINSEY, KORTZ, LONGIETTI,
MILLARD, NEILSON, OBERLANDER, PICKETT, READSHAW, RYAN, SONNEY
AND TOPPER, APRIL 29, 2019
INTRODUCED AS NONCONTROVERSIAL RESOLUTION UNDER RULE 35,
APRIL 29, 2019
A RESOLUTION
Designating the week of May 5 through 11, 2019, as "Tardive
Dyskinesia Awareness Week" in Pennsylvania.
WHEREAS, Tardive Dyskinesia is a condition of involuntary
muscle movements of the face, trunk and extremities that can
vary in frequency and amplitude; and
WHEREAS, Tardive Dyskinesia is a condition that may occur
with certain medications used to treat mental illness, may
result from treatment with dopamine receptor blocking agents
used for both psychiatric and nonpsychiatric conditions and can
persist even after discontinuing those treatments; and
WHEREAS, Research done by The Citizens Commission on Human
Rights shows that more than 12,000,000 Americans take
antipsychotics and more than 500,000 of those patients may have
Tardive Dyskinesia; and
WHEREAS, Anyone taking antipsychotic medication may develop
the condition, but people who are elderly, female, diabetic or
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
have a mental illness are at a greater risk; and
WHEREAS, The House of Representatives believes that it is in
the interest of Pennsylvania to increase public awareness of
Tardive Dyskinesia, a neurological disorder that is
characterized by repetitive, involuntary muscle movements and
may occur as a side effect of long-term use of antipsychotic and
other medications; therefore be it
RESOLVED, That the House of Representatives designate the
week of May 5 through 11, 2019, as "Tardive Dyskinesia Awareness
Week" in Pennsylvania.
20190HR0284PN1613 - 2 -
1
2
3
4
5
6
7
8
9
10